EUVIMEDEUVIMED entdecken
Kontrollierte klinische StudieMultizentrische StudieOpen Access · CC BY 4.0

Hospital costs of different treatment strategies for anastomotic leakage after total mesorectal excision: a multicentre cost analysis

D J Nijssen iD, K Wienholts iD, M J Postma iD, W A Bemelman iD, J Tuynman iD, W Laméris, P J Tanis, R Hompes iD, IMARI-study group

Techniques in Coloproctology · 2025

DOI: 10.1007/s10151-025-03215-2 ↗

Kurz gefasst

Kontrollierte klinische Studie in der Zeitschrift Techniques in Coloproctology, 2025. Verfasst von D J Nijssen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Amsterdam UMC Location University of Amsterdam, Amsterdam, the Netherlands. d.nijssen@amsterdamumc.nl. Hauptthemen laut MEDLINE: Anastomotic Leak, Hospital Costs, Proctectomy, Rectal Neoplasms. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Styker European Operations B.V..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Limited data exist on hospital costs incurred by anastomotic leakage (AL), particularly in relation to specific treatment approaches. This study aimed to analyse the incremental hospital costs of AL after total mesorectal excision (TME), stratified by treatment strategy, over a 1-year time horizon.

Methods

Patients undergoing total mesorectal excision (TME) for rectal cancer (2020–2023), included in the control cohort of the IMARI-study at 15 Dutch centres, were analysed. A cost analysis was conducted according to Dutch National Healthcare Institute guidelines. The primary outcome was the incremental hospital costs incurred by patients with AL detected within 30 days postoperatively, stratified by treatment strategy.

Results

The analysis compared treatment costs in 32 patients with AL and 82 patients without AL. The average hospital costs per patient in the first postoperative year were €15.312. In patients with AL, the mean incremental costs were €24.333. Major cost drivers in the AL group were prolonged hospitalization (+€13.150) and (re)interventions (+€8.910). The treatment costs differed significantly between strategies: no faecal diversion (€10.062), faecal diversion with passive drainage (€23.903), faecal diversion with active drainage (€35.552), and salvage surgery (€38.793).

Conclusions

AL after TME resulted in a nearly fourfold increase in hospital costs compared with patients without AL. Salvage surgery was the most expensive treatment strategy, followed by faecal diversion with active drainage. Future studies should evaluate how these treatment costs relate to clinical success rates, including rates of chronic pelvic sepsis and permanent stomas.

Trial registration

This study used data from the IMARI-study. The IMARI-study is registered with the Dutch Central Committee on Research Involving Human Subjects (NL67600.018.18) and is submitted to the http://www.onderzoekmetmensen.nl/en database (NL-OMON26456 and NL-OMON55903).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anastomotic LeakHospital CostsProctectomyRectal NeoplasmsAgedFemaleHumansMaleMiddle AgedDrainageNetherlands

Stichwörter der Autor:innen

Anastomotic leakageCost analysisHospital costsRectal cancerTotal mesorectal excisionTreatment strategies

Autor:innen und Institutionen

  • Department of Surgery, Amsterdam UMC Location University of Amsterdam, Amsterdam, the Netherlands. d.nijssen@amsterdamumc.nl.
  • Cancer Center Amsterdam, Treatment and Quality of Life, Amsterdam, The Netherlands. d.nijssen@amsterdamumc.nl.
  • Department of Surgery, Amsterdam UMC Location University of Amsterdam, Amsterdam, the Netherlands.
  • Cancer Center Amsterdam, Treatment and Quality of Life, Amsterdam, The Netherlands.
  • Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands.
  • Department of Health Sciences, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

ORCID-Profile: D J Nijssen, K Wienholts, M J Postma, W A Bemelman, J Tuynman, R Hompes

Förderung

  • Styker European Operations B.V.

Zitieren

APA

Nijssen, D. J., Wienholts, K., Postma, M. J., Bemelman, W. A., Tuynman, J., Laméris, W., Tanis, P. J., Hompes, R., & IMARI-study group (2025). Hospital costs of different treatment strategies for anastomotic leakage after total mesorectal excision: a multicentre cost analysis. Techniques in Coloproctology. https://doi.org/10.1007/s10151-025-03215-2

Vancouver

Nijssen DJ, Wienholts K, Postma MJ, Bemelman WA, Tuynman J, Laméris W, et al. Hospital costs of different treatment strategies for anastomotic leakage after total mesorectal excision: a multicentre cost analysis. Techniques in Coloproctology. 2025. doi:10.1007/s10151-025-03215-2

BibTeX
@article{Nijssen2025,
  author = {Nijssen, D J and Wienholts, K and Postma, M J and Bemelman, W A and Tuynman, J and Laméris, W and Tanis, P J and Hompes, R and IMARI-study group, IMARI-study group},
  title = {Hospital costs of different treatment strategies for anastomotic leakage after total mesorectal excision: a multicentre cost analysis},
  journal = {Techniques in Coloproctology},
  year = {2025},
  doi = {10.1007/s10151-025-03215-2}
}
Kostenlos starten →